Natural Capsules Ltd.
Plans to foray into APIs through subsidiary Natural Biogenex is looking good for long term
Other reasons -
- Increase in promoter holding
- Low debt
- PLI awardee
May give good returns by H2 FY23 once API + expanded capsule capacity will be started.
CMP 190
Plans to foray into APIs through subsidiary Natural Biogenex is looking good for long term
Other reasons -
- Increase in promoter holding
- Low debt
- PLI awardee
May give good returns by H2 FY23 once API + expanded capsule capacity will be started.
CMP 190
Natural Capsules,
Update -
CMP - 239, more than 25% returns in 5 days.
Update -
CMP - 239, more than 25% returns in 5 days.
Natural Capsules,
Update -
CMP - 244,
Now trading ex rights issue,
So recommended price - 160
More than 50% returns in 1-1.5 months
Update -
CMP - 244,
Now trading ex rights issue,
So recommended price - 160
More than 50% returns in 1-1.5 months
Natural Capsules,
Update -
CMP - 292,
Now trading ex rights issue,
So recommended price - 160
More than 75% returns in 1.5-2 months
Update -
CMP - 292,
Now trading ex rights issue,
So recommended price - 160
More than 75% returns in 1.5-2 months
Natural Capsules,
Update -
CMP - 330
Now trading ex rights issue,
So recommended price - 160
More than 100% returns in 2 months
Update -
CMP - 330
Now trading ex rights issue,
So recommended price - 160
More than 100% returns in 2 months
Loading suggestions...